Search
01/02/2022
Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
El-Chami, MF, Garweg, C, Iacopino, S, Al-Samadi, F, Martinez-Sande, JL, Tondo, C, Johansen, JB, Prat, XV, Piccini, JP, Cha, YM, Grubman, E, Bordachar, P, Roberts, PR, Soejima, K, Stromberg, K, Fagan, DH, Clementy, N. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry. HEART RHYTHM. 2022; 19(2)DOI:10.1016/j.hrthm.2021.10.023. PMID:34757189. IF:5.500(Q2/3D).
01/02/2022
Ruptured sinus of Valsalva aneurysm: A reversible cause of suprasystemic pulmonary hypertension
Asmarats, L, Bethencourt, A, Rodriguez, A, Noris, M, Maristany, J, Grau, A, Gomez-Jaume, A, Peral, V. Ruptured sinus of Valsalva aneurysm: A reversible cause of suprasystemic pulmonary hypertension. Revista Portuguesa de Cardiologia. 2022; 41(2)DOI:10.1016/j.repc.2018.10.016. PMID:36062706. IF:1.800(Q4/8D).
01/02/2022
Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries)
Vilades-Medel, D, Degano, IR, Subirana, I, Descalzo, M, Padilla, M, Mundet, X, Costa, FC, Serrallach, XA, Camps, A, Elosua, R, Marrugat, J, Petracca, RL. Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries). Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030533. PMID:35159985. IF:3.900(Q2/4D).
01/02/2022
Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
Jimenez-Yuste, V, Alvarez-Roman, MT, Bravo, AP, Galmes, BJ, Hernandez, MDN, Hidalgo, OB, Alonso, CM, Gonzalez, NFP, Coll, J, Nunez, R, Carrasco, M, Candel, FG, Gonzalez-Porras, JR, Garcia, CH, Castro, MJV, Mir, R. Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2022; 28DOI:10.1177/10760296221074348. PMID:35108125. IF:2.900(Q3/6D).